Colorectal patients want a better experience. Let's give them one.
Colon and rectal surgery
Three resons why we are dedicated to transforming colorectal health:
- Get faster recoveries
- Enhance hospital efficiencies
- Improve lives for the long-term
The situation we face today
We'll transform colorectal health together
To transform colorectal care, we don’t just need technologies that lower complication rates, we also need to solve healthcare challenges and invest in professional training.
Our aim is to collaborate with healthcare providers to ensure their patients recover more quickly, achieve better long-term outcomes, and have the best possible experience with colorectal treatment.
Medtronic will do this by working with you as we aim to become your trusted partner in Colorectal Health.
Partnership
Whether you want to develop a treatment strategy, find high-quality training, or source the best surgical equipment; we partner with healthcare professionals like you to overcome Colorectal Health challenges and improve patient outcomes.
Surgical Innovation
As a quality healthcare provider, you want to give your Colorectal patients the best experience from the moment they’re diagnosed up until discharge.
We support all approaches to surgery from Open to Minimally Invasive to advanced MIS & robotics techniques as our aim is to work to improve complication rates associated with colorectal resections with enhanced focus on that of anastomotic leakage.
Training & Education
Advancing your team’s knowledge and providing best-in-class training will help you to deliver high-quality treatments for your Colorectal patients.
Whether it’s in-theatre or remote training, we’ll match our education courses to suit your team’s needs so they can be inspired, grow professionally and improve their patient outcomes.
* Based on staple-line vascularity analysis using MicroCT in an in vivo canine model (CDH31P: n = 13; TRIEEA31XT: n = 15. P = 0.007).
† Preclinical results may not correlate with clinical performance in humans.
‡ Bench test results may not necessarily be indicative of clinical performance
§ Thick tissue is defined as non-dissected vascular tissue or fatty tissue. ††Bench tissue may not be indicative of clinical tissue performance
- https://www.cancer.org/cancer/colon-rectal-cancer/about/key-statistics.html Accessed 02/02/2022
- European Comission. ECIR Uncovering Inequalities. Colorectal Cancer Screening in Europe.
- Ait Ouakrim D, Pizot C, Boniol M, et al. Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database. BMJ. 2015;351:h4970. Published 2015 Oct 6. doi:10.1136/bmj.h4970
- Morgan E, Arnold M, Gini A, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72(2):338-344. doi:10.1136/gutjnl-2022-327736
- Dong, J., Lei, Y., Wan, Y. et al. Enhanced recovery after surgery from 1997 to 2022: a bibliometric and visual analysis. Updates Surg 76, 1131–1150 (2024). https:// doi.org/10.1007/s13304-024-01764-z
- Matsuhashi N. et Al., Evaluation of the SYNAPSE VINCENT for lateral lymph node dissection in rectal cancer with RAS. World Journal of Surgical Oncology (2022) 20:56 https://doi.org/10.1186/s12957-022-02532-2
- Based on internal report #RE00318260, Comparative leak testing for EEA™ circular stapler with Tri-Staple™ technology and Ethicon™* CDH. April 2021.
- Catarci M, Guadagni S, Masedu F, Ruffo G, Viola MG, Borghi F, Baldazzi G, Scatizzi M; Italian ColoRectal Anastomotic Leakage (iCral) study group. Three-row versus two-row circular staplers for left-sided colorectal anastomosis: a propensity score-matched analysis of the iCral 2 and 3 prospective cohorts. Int J Surg. 2023 Aug 1;109(8):2312-2323. doi: 10.1097/JS9.0000000000000480. PMID: 37195782; PMCID: PMC10442086.